Home parenteral nutrition in patients with systemic sclerosis: A retrospective review of 12 cases

Journal of Rheumatology

Volumn 39, Issue 5, 2012, Pages 1004-1007

  Jawa, Hani ^a   Fernandes, Gail ^a   Saqui, Olivia ^a   Allard, Johanne P ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bacterial overgrowth; Home parenteral nutrition; Intestinal pseudoobstruction; Scleroderma; Systemic sclerosis

Indexed keywords

ANTIBIOTIC AGENT; PROKINETIC AGENT;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BODY MASS; CANADA; CLINICAL ARTICLE; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; FUNCTIONAL STATUS; HOME CARE; HUMAN; INTESTINE PSEUDOOBSTRUCTION; KARNOFSKY PERFORMANCE STATUS; MALE; MALNUTRITION; MEDICAL RECORD REVIEW; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMIC SCLEROSIS; TOTAL PARENTERAL NUTRITION;

ADULT; BLIND LOOP SYNDROME; BODY WEIGHT; FEMALE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; PARENTERAL NUTRITION, HOME; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860703200     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110896     Document Type: Article

References (12)

1. Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006;23:691-712. (Pubitemid 43344588)
2. Forbes A, Marie I. Gastrointestinal complications: The most frequent internal complications of systemic sclerosis. Rheumatology 2009;48 Suppl 3:iii36-9.
3. Baron M, Hudson M, Steele R; Canadian Scleroderma Research Group. Malnutrition is common in systemic sclerosis: Results from the Canadian Scleroderma Research Group database. J Rheumatol 2009;36:2737-43.
4. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987;11:8-13. (Pubitemid 17009508)
5. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984;2:187-93. (Pubitemid 14138407)
6. Ng SC, Clements PJ, Berquist WE, Furst DE, Paulus HE. Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum 1989;32:212-6. (Pubitemid 19056411)
7. Brown M, Teubner A, Shaffer J, Herrick AL. Home parenteral nutrition - An effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology 2008;47:176-9. (Pubitemid 351168227)
8. Baron M, Hudson M, Steele R; Canadian Scleroderma Research Group. Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm. J Am Coll Nutr 2010;29:144-51.
9. Amiot A, Joly F, Alves A, Panis Y, Bouhnik Y, Messing B. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol 2009;104:1262-70.
10. Altman RD, Medsger TA Jr, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
11. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002;81:154-67. (Pubitemid 34218570)
12. Grabowski G, Grant JP. Nutritional support in patients with systemic scleroderma. JPEN J Parenter Enteral Nutr 1989;13:147-51. (Pubitemid 19096626)